Advertisement

Psychopharmacology and Aging

  • Carl Eisdorfer
  • William E. Fann

Part of the Advances in Behavioral Biology book series (ABBI, volume 6)

Table of contents

  1. Front Matter
    Pages i-xx
  2. Introduction

    1. Front Matter
      Pages 1-1
  3. Bases of a Psychopharmacology for the Aging

    1. Front Matter
      Pages 9-9
    2. Oakley S. Ray, Robert J. Barrett
      Pages 17-39
    3. Alexander Nies, Donald S. Robinson, John M. Davis, C. Lewis Ravaris
      Pages 41-54
    4. G. A. Robison, M. J. Schmidt, G. C. Palmer
      Pages 55-75
  4. Complications of Drug Use

    1. Front Matter
      Pages 81-81
    2. George W. Paulson
      Pages 83-88
    3. William E. Fann, John M. Davis, Ian C. Wilson, C. Ray Lake
      Pages 89-96
    4. Donald R. Jasinski
      Pages 105-109
    5. John M. Davis, William E. Fann, M. Khaled El-Yousef, David S. Janowsky
      Pages 111-125
  5. Issues in Clinical Management of Drugs

    1. Front Matter
      Pages 127-127
    2. Carl Salzman, Richard I. Shader
      Pages 159-168
    3. Adriaan Verwoerdt
      Pages 169-181
    4. Samuel Gershon
      Pages 183-187
    5. Bernard A. Stotsky
      Pages 193-202
    6. Alan D. Whanger
      Pages 203-211
    7. William W. K. Zung, Robert L. Green Jr.
      Pages 213-224
    8. Arthur J. Prange Jr.
      Pages 225-237
    9. William P. Wilson, L. Frank Major
      Pages 239-244
  6. Back Matter
    Pages 245-253

About this book

Introduction

This volume represents the proceedings of a Symposium on Psychopharmacology and the Aging Patient, held at Duke University, May 29-31, 1972. The conference was jointly sponsored by the Center for the Study of Aging and Human Development and the Department of Psychiatry at Duke. This Symposium was the first in a series of conferences which will be devoted variously to preclinical and clinical pharmacology of the different groups of psychotropic drugs, especially as they relate to the problems of the elderly patient and to the special considerations that must be given in theory and in practice to changes brought about by the process of aging. The idea behind this particular symposium was to bring basic and clinical scientists together with practicing clinicians and other mental health professionals for an exchange of ideas and interests through formal didactic and informal small sessions. The major interest, of course, was to disseminate current information on the clinical use and indication for psychoactive agents, particularly as they related to the elderly patient. Recognition and management of psychiatric syndromes of the elderly were included as they were pertinent to psychopharmacology of aging to indicate the direction of ongoing work and to stimulate further research in this area. The editors wish to gratefully acknowledge the generous financial support xiii xiv Foreword of the Symposium granted by the following pharmaceutical firms: Smith-Kline-French Laboratories Pfizer Laboratories and Abbott Laboratories Burroughs-Wellcome Company CIBA - Geigy Corporation Lakeside Laboratories McNeil Laboratories, Inc.

Keywords

cognition pharmacology psychiatry psychopharmacology research

Editors and affiliations

  • Carl Eisdorfer
    • 1
  • William E. Fann
    • 2
    • 3
  1. 1.Department of Psychiatry and Behavioral SciencesUniversity of Washington Medical SchoolSeattleUSA
  2. 2.Departments of Psychiatry and Pharmacology, Center for The Study of Aging and Human DevelopmentDuke University Medical SchoolDurhamUSA
  3. 3.Veterans Administration HospitalDurhamUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-4684-7770-2
  • Copyright Information Springer-Verlag US 1973
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4684-7772-6
  • Online ISBN 978-1-4684-7770-2
  • Series Print ISSN 0099-6246
  • Buy this book on publisher's site